Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 15.85
-0.17 (-1.06%)
Nov 10, 2026, 4:08 PM HKT
HKG:6826 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 109.26 | 251.01 | 420.45 | 416.12 | 180.47 | 352.23 |
Depreciation & Amortization | 205 | 205 | 203.86 | 197.86 | 200.89 | 159.95 |
Other Amortization | 1.76 | 1.76 | 1.37 | - | 3.33 | 2.89 |
Loss (Gain) From Sale of Assets | 0.2 | 0.2 | 0.02 | -0.59 | 0.51 | 0.37 |
Asset Writedown & Restructuring Costs | 176.16 | 176.16 | - | - | 46.07 | - |
Loss (Gain) From Sale of Investments | -31.06 | -31.06 | -25.92 | -2.3 | 7.78 | -0.02 |
Loss (Gain) on Equity Investments | -0.01 | -0.01 | -0.99 | -0.46 | -3.51 | -2.19 |
Stock-Based Compensation | - | - | 3 | 14.3 | 30.23 | - |
Provision & Write-off of Bad Debts | 4.92 | 4.92 | -2.23 | -1.97 | 15.52 | -3.18 |
Other Operating Activities | -167.37 | -139.3 | -93.7 | -61.7 | -66.5 | -191.69 |
Change in Accounts Receivable | -12.17 | -12.17 | -39.35 | 10.13 | -52.33 | -41.92 |
Change in Inventory | -50.13 | -50.13 | 5.32 | -48.42 | -138.86 | -28.63 |
Change in Accounts Payable | 66.01 | 66.01 | 62.62 | 43.48 | 35.44 | 32.35 |
Change in Other Net Operating Assets | 18.59 | 18.59 | 114.12 | 67.99 | -27.75 | 62.13 |
Operating Cash Flow | 321.16 | 490.97 | 648.57 | 634.45 | 231.3 | 342.29 |
Operating Cash Flow Growth | -46.02% | -24.30% | 2.23% | 174.30% | -32.43% | 30.61% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -201.42 | -184.19 | -362.18 | -265.6 | -309.21 | -270.88 |
Sale of Property, Plant & Equipment | 6.27 | 5.91 | 0.72 | 1.84 | 0.39 | 0.21 |
Cash Acquisitions | - | - | -17.58 | - | -2.94 | -83.28 |
Divestitures | 80.58 | 80.58 | - | - | 17.59 | - |
Sale (Purchase) of Intangibles | -2.75 | -2.75 | -1.31 | -1.63 | -7.94 | -1.22 |
Investment in Securities | 492.96 | 298.16 | 586.14 | -189.68 | -468.55 | 52.67 |
Other Investing Activities | 77.49 | 76.91 | 73.98 | 78.42 | 88.84 | 154.4 |
Investing Cash Flow | 379.07 | 200.55 | 282.28 | -376.65 | -681.82 | -148.09 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 235.89 | 242 | 313.89 | 65.94 | 38.01 |
Long-Term Debt Repaid | - | -311.42 | -221.08 | -40.93 | -69.7 | -119.5 |
Lease Payments | -24.33 | -24.33 | -23.36 | -24.55 | -21.79 | -23.96 |
Net Debt Issued (Repaid) | 11.78 | -75.52 | 20.92 | 272.96 | -3.76 | -81.49 |
Issuance of Common Stock | - | - | 49.45 | 73.68 | - | - |
Repurchase of Common Stock | -148.62 | -148.62 | -175.35 | -269.98 | -147.67 | -44.91 |
Common Dividends Paid | -274.25 | -228.74 | -259.86 | -68.52 | -121.89 | -87.91 |
Other Financing Activities | -35.49 | -127.78 | -25.51 | -265.87 | -15.03 | -16.94 |
Financing Cash Flow | -446.58 | -580.66 | -390.35 | -257.73 | -288.35 | -231.25 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -26.47 | 4.63 | 3.08 | 10.05 | 14.17 | -6.94 |
Net Cash Flow | 227.18 | 115.49 | 543.59 | 10.12 | -724.7 | -43.99 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 119.75 | 306.78 | 286.39 | 368.85 | -77.91 | 71.41 |
Free Cash Flow Growth | -68.30% | 7.12% | -22.36% | - | - | -1.34% |
Free Cash Flow Margin | 5.30% | 12.54% | 10.69% | 14.00% | -3.70% | 4.08% |
Free Cash Flow Per Share | 0.52 | 1.32 | 1.23 | 1.55 | -0.23 | 0.21 |
Levered Free Cash Flow | -44.87 | 195.32 | 198.35 | 209.26 | -112.91 | -9.78 |
Unlevered Free Cash Flow | -33.69 | 207.12 | 209.64 | 213.82 | -108.16 | -6.68 |
Free Cash Flow After Leases | 95.42 | 282.45 | 263.04 | 344.3 | -99.7 | 47.44 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 16.82 | 16.82 | 18.06 | 5.1 | 4.99 | 3 |
Cash Income Tax Paid | 60.99 | 78.26 | 115.59 | 88.19 | 43.72 | 70.22 |
Change in Working Capital | 22.3 | 22.3 | 142.71 | 73.19 | -183.49 | 23.93 |